Verseon Corp. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
- |
Public Float |
- |
Verseon Corp. | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.11 |
Market Cap |
GBP209.94 M |
Shares Outstanding |
151.58 M |
Public Float |
- |
Address |
47071 Bayside Parkway Fremont California 94538 United States |
Employees | - |
Website | http://www.verseon.com |
Updated | 09/14/2018 |
Verseon Corp. engages in the development and design of pharmaceutical products. It focuses on drug discovery technology to seed a growing portfolio of programs targeting diverse disease areas, currently consisting of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. The company was founded by Eniko Fodor, David Kita, and Adityo Prakash in 2002 and is headquartered in Fremont, CA. |